Literature DB >> 2442260

Macrophage membrane interleukin 1 regulates the expression of acute phase proteins in human hepatoma Hep 3B cells.

H U Beuscher, R J Fallon, H R Colten.   

Abstract

To assess the potential role of membrane interleukin 1 (mIL-1) in modulating expression of acute phase proteins, we studied the effect of fixed mouse peritoneal macrophages and isolated cell membranes on the synthesis of C3 and albumin in human hepatoma Hep 3B cells. An increase in C3 synthesis and decrease in albumin synthesis were detected after incubation of Hep 3B cells with fixed stimulated macrophages or with membrane preparations. Estimates of hepatocellular C3 and albumin mRNA indicated that the mIL-1 regulation was exerted at a pretranslational level. The changes in C3 and albumin expression induced by mIL-1 were inhibited by addition of anti-interleukin 1 (IL-1) antiserum to the macrophages, supporting the hypothesis that a form of IL-1 is present on the outer cell membrane of macrophages. Moreover, cell-surface iodination of macrophages allowed the detection of a 33-kDa IL-1 molecule, suggesting that an IL-1 species, similar to the intracellular precursor of IL-1 is present at the outer cell surface of macrophages. The expression of mIL-1 was temporally dissociated from IL-1 release, indicating that the cell-surface associated IL-1 activity is not the result of adsorbed soluble IL-1. These studies provide a basis for further investigation of the role of mIL-1 in modulating monocytes and macrophages function via cell-cell interactions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Stimulation of the acute-phase response in simian virus 40-hepatocyte cell lines.

Authors:  W S Liao; K T Ma; C D Woodworth; L Mengel; H C Isom
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

Review 2.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

3.  Differential regulation of soluble interleukin 1 release and membrane expression by pharmacologic agents.

Authors:  S R Brandwein
Journal:  Agents Actions       Date:  1990-06

4.  Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA.

Authors:  R C Fuhlbrigge; S M Fine; E R Unanue; D D Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

Review 5.  Interleukin-1 and the effects of cyclooxygenase inhibitors on its biological activities.

Authors:  C A Dinarello
Journal:  Bull N Y Acad Med       Date:  1989-01

Review 6.  Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function.

Authors:  P Stanley; V Koronakis; C Hughes
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

7.  The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece.

Authors:  F T Stevenson; S L Bursten; C Fanton; R M Locksley; D H Lovett
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

8.  C-reactive protein protects against preerythrocytic stages of malaria.

Authors:  S Pied; A Nussler; M Pontent; F Miltgen; H Matile; P H Lambert; D Mazier
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

9.  Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease.

Authors:  T D Yule; M B Roth; K Dreier; A F Johnson; M Palmer-Densmore; K Simmons; R Fanton
Journal:  Vaccine       Date:  1997 Apr-May       Impact factor: 3.641

10.  Expression of membrane-associated lymphotoxin/tumor necrosis factor-beta on human lymphokine-activated killer cells.

Authors:  Y Abe; M Miyake; A Horiuchi; S Kimura; Y Hitsumoto
Journal:  Jpn J Cancer Res       Date:  1991-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.